Organogenesis Holdings Inc. (ORGO) Free Cash Flow
Organogenesis Holdings Inc. (ORGO) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2016-12-31 | -$562.23K |
| 2017-12-31 | -$3.00M |
| 2018-12-31 | -$62.49M |
| 2019-12-31 | -$39.76M |
| 2020-12-31 | -$12.21M |
| 2021-12-31 | $30.76M |
| 2022-12-31 | -$9.04M |
| 2023-12-31 | $6.55M |
| 2024-12-31 | $4.18M |
| 2025-12-31 | -$24.46M |
How ORGO compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| TXMD | TherapeuticsMD Inc. | $2.45M |
| RMTI | Rockwell Medical Inc. | -$1.24M |
| AXGN | Axogen Inc. | -$4.78M |
| SPRO | Spero Therapeutics Inc. | -$12.62M |
| IART | Integra LifeSciences Holdings Corporation | -$45.25M |
These are five companies in the same sector as ORGO with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Organogenesis Holdings Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("ORGO", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | ORGO | $1.75 | +0.57% | 0.38M |
| 3 | ||||
| 4 | ||||
| 5 |